Literature DB >> 9368630

Host cell factor CD59 restricts complement lysis of Plasmodium falciparum-infected erythrocytes.

J Wiesner1, H Jomaa, M Wilhelm, H P Tony, P G Kremsner, P Horrocks, M Lanzer.   

Abstract

Here we demonstrate that components of the entire complement cascade are fixed on the surface of erythrocytes infected with the human malarial parasite Plasmodium falciparum. Despite the activation of lytic complement factors, no complement-mediated lysis of P. falciparum-infected erythrocytes occurred only in the absence of functional intrinsic CD59. These data suggest that the restriction of the complement attack of P. falciparum-infected erythrocytes is principally mediated by intrinsic host cell factors, in particular CD59.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368630     DOI: 10.1002/eji.1830271034

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection.

Authors:  S Lauer; J VanWye; T Harrison; H McManus; B U Samuel; N L Hiller; N Mohandas; K Haldar
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

2.  Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.

Authors:  P R Taylor; E Seixas; M J Walport; J Langhorne; M Botto
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia.

Authors:  Rolf Fendel; Christian Brandts; Annika Rudat; Andrea Kreidenweiss; Claudia Steur; Iris Appelmann; Bettina Ruehe; Paul Schröder; Wolfgang E Berdel; Peter G Kremsner; Benjamin Mordmüller
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

4.  Early and extensive CD55 loss from red blood cells supports a causal role in malarial anaemia.

Authors:  Moses Gwamaka; Michal Fried; Gonzalo Domingo; Patrick E Duffy
Journal:  Malar J       Date:  2011-12-29       Impact factor: 2.979

5.  Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia.

Authors:  Damian A Oyong; Enny Kenangalem; Jeanne R Poespoprodjo; James G Beeson; Nicholas M Anstey; Ric N Price; Michelle J Boyle
Journal:  JCI Insight       Date:  2018-11-15

6.  Loss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infection.

Authors:  Damian A Oyong; Jessica R Loughland; Arya SheelaNair; Dean Andrew; Fabian D L Rivera; Kim A Piera; Timothy William; Matthew J Grigg; Bridget E Barber; Ashraful Haque; Christian R Engwerda; James S McCarthy; Nicholas M Anstey; Michelle J Boyle
Journal:  Malar J       Date:  2019-09-18       Impact factor: 2.979

Review 7.  Complement in malaria immunity and vaccines.

Authors:  Liriye Kurtovic; Michelle J Boyle; D Herbert Opi; Alexander T Kennedy; Wai-Hong Tham; Linda Reiling; Jo-Anne Chan; James G Beeson
Journal:  Immunol Rev       Date:  2019-09-26       Impact factor: 12.988

Review 8.  IgM, Fc mu Rs, and malarial immune evasion.

Authors:  Daniel M Czajkowsky; Ali Salanti; Sisse B Ditlev; Zhifeng Shao; Ashfaq Ghumra; J Alexandra Rowe; Richard J Pleass
Journal:  J Immunol       Date:  2010-05-01       Impact factor: 5.422

9.  Increased expression of complement regulators CD55 and CD59 on peripheral blood cells in patients with EAHEC O104:H4 infection.

Authors:  Werner Dammermann; Pim Schipper; Sebastian Ullrich; Katharina Fraedrich; Julian Schulze Zur Wiesch; Thorben Fründt; Gisa Tiegs; Ansgar Lohse; Stefan Lüth
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

10.  Evasion of Classical Complement Pathway Activation on Plasmodium falciparum-Infected Erythrocytes Opsonized by PfEMP1-Specific IgG.

Authors:  Mads Delbo Larsen; Maria Del Pilar Quintana; Sisse Bolm Ditlev; Rafael Bayarri-Olmos; Michael Fokuo Ofori; Lars Hviid; Peter Garred
Journal:  Front Immunol       Date:  2019-01-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.